Phaos Technology Holdings (Cayman) (POAS) Accounts Payables (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Accounts Payables of $44581.0 for Q4 2025, down 36.56% on a QoQ basis from $70270.1 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Accounts Payables data on file, last reported at $44581.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables changed N/A year-over-year to $44581.0; the trailing twelve-month figure through Oct 2025 stood at $44581.0 (changed N/A YoY), and the FY2025 full-year result was $39388.0, down 13.66% from the prior year.
- Accounts Payables for Q4 2025 stood at $44581.0, down from $70270.1 in the prior quarter.
- Across five years, Accounts Payables topped out at $70270.1 in Q2 2025 and bottomed at $44581.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.57 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.33 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 338.80 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | 44,581.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 44,581.00 |
| Apr 30, 2025 | 70,270.08 |
| Apr 30, 2024 | 45,621.08 |